These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34420077)

  • 21. Incidence and Risk Factors of Left Ventricular Thrombus in Acute ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Meta-Analysis.
    Wang P; Ye X; Yan D; Peng Y; Zhang Z
    Med Princ Pract; 2022; 31(5):415-423. PubMed ID: 35797977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial.
    Puymirat E; Soulat G; Fayol A; Mousseaux E; Montalescot G; Cayla G; Steg PG; Berard L; Rousseau A; Drouet É; Simon T; Danchin N;
    Am Heart J; 2023 Dec; 266():98-105. PubMed ID: 37716448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI).
    Gibson CM; Mehran R; Bode C; Halperin J; Verheugt F; Wildgoose P; van Eickels M; Lip GY; Cohen M; Husted S; Peterson E; Fox K
    Am Heart J; 2015 Apr; 169(4):472-8.e5. PubMed ID: 25819853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-vitamin K oral anticoagulants versus warfarin for the treatment of left ventricular thrombus.
    Kam KKH; Chan JSK; Lee APW
    Hong Kong Med J; 2024 Feb; 30(1):10-15. PubMed ID: 38327164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type.
    Eyileten C; Postula M; Jakubik D; Toma A; Mirowska-Guzel D; Patti G; Renda G; Siller-Matula JM
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32295160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus.
    Iqbal H; Straw S; Craven TP; Stirling K; Wheatcroft SB; Witte KK
    ESC Heart Fail; 2020 Oct; 7(5):2032-2041. PubMed ID: 32583975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of left ventricular thrombus: a narrative review.
    Cruz Rodriguez JB; Okajima K; Greenberg BH
    Ann Transl Med; 2021 Mar; 9(6):520. PubMed ID: 33850917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of left ventricular thrombus formation and adverse outcomes in acute anterior myocardial infarction in patients treated with primary percutaneous coronary intervention.
    Zhang Q; Wang CM; Shi ST; Chen H; Zhou YJ
    Clin Cardiol; 2019 Jan; 42(1):69-75. PubMed ID: 30367476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
    Nikolsky E; Mehran R; Dangas GD; Yu J; Parise H; Xu K; Pocock SJ; Stone GW
    Am J Cardiol; 2012 Mar; 109(6):831-8. PubMed ID: 22196778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and predictors of early left ventricular thrombus after ST-elevation myocardial infarction in the contemporary era of primary percutaneous coronary intervention.
    Gianstefani S; Douiri A; Delithanasis I; Rogers T; Sen A; Kalra S; Charangwa L; Reiken J; Monaghan M; MacCarthy P
    Am J Cardiol; 2014 Apr; 113(7):1111-6. PubMed ID: 24485697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature.
    Kajy M; Shokr M; Ramappa P
    Am J Ther; 2020; 27(6):e584-e590. PubMed ID: 30730331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.
    Chi G; Yee MK; Kalayci A; Kerneis M; AlKhalfan F; Mehran R; Bode C; Halperin JL; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Peterson ED; Fox KAA; Gibson CM
    J Thromb Thrombolysis; 2018 Oct; 46(3):346-350. PubMed ID: 29943350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic Therapy and Outcomes of Patients With New-Onset Transient Atrial Fibrillation After ST-Segment Elevation Myocardial Infarction.
    Kayapinar O; Kaya A; Keskin M; Tatlisu MA
    Am J Ther; 2021 Jan-Feb 01; 28(1):e30-e40. PubMed ID: 30299271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data.
    Cochran JM; Jia X; Kaczmarek J; Staggers KA; Rifai MA; Hamzeh IR; Birnbaum Y
    J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):173-178. PubMed ID: 33078629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin for stroke prevention following anterior ST-elevation myocardial infarction.
    Buss NI; Friedman SE; Andrus BW; DeVries JT
    Coron Artery Dis; 2013 Dec; 24(8):636-41. PubMed ID: 23974463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-vitamin K oral antagonist (NOAC) compared to vitamin K antagonist (VKA) in left ventricular thrombus.
    Al-Kaf F; Al Basiri S; Al Ash'hab Y; Otain M; Al Askary H; Khushail AA; Robert AA; Al Fagih A
    J Family Med Prim Care; 2024 Jun; 13(6):2485-2490. PubMed ID: 39027879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial.
    Mahaffey KW; Wojdyla D; Hankey GJ; White HD; Nessel CC; Piccini JP; Patel MR; Berkowitz SD; Becker RC; Halperin JL; Singer DE; Califf RM; Fox KA; Breithardt G; Hacke W
    Ann Intern Med; 2013 Jun; 158(12):861-8. PubMed ID: 23778903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved detection of echocardiographically occult left ventricular thrombi following ST-elevation myocardial infarction.
    Reindl M; Lechner I; Holzknecht M; Tiller C; Fink P; Oberhollenzer F; Mayr A; Troger F; Pamminger M; Henninger B; Theurl M; Klug G; Brenner C; Bauer A; Metzler B; Reinstadler SJ
    Eur Heart J Acute Cardiovasc Care; 2023 Oct; 12(10):703-710. PubMed ID: 37348047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Inflammation in Early Left Ventricular Thrombus Formation Following ST-Elevation Myocardial Infarction-A Matched Case-Control Study.
    Litmanowicz B; Perelman MG; Laufer-Perl M; Topilsky Y; Banai S; Shacham Y; Khoury S
    Clin Cardiol; 2024 Oct; 47(10):e70031. PubMed ID: 39412036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct oral anticoagulants versus vitamin K antagonists for patients with left ventricular thrombus.
    Xu Z; Li X; Li X; Gao Y; Mi X
    Ann Palliat Med; 2021 Sep; 10(9):9427-9434. PubMed ID: 34628868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.